Hepatitis C guidance 2018 update: Aasld-idsa recommendations for testing, managing, and treating Hepatitis C Virus infection

Raymond T. Chung; Marc G. Ghany; Arthur Y. Kim; Kristen M. Marks; Susanna Naggie; Hugo E. Vargas; Andrew I. Aronsohn; Debika Bhattacharya; Tina Broder; Oluwaseun O. Falade-Nwulia; Robert J. Fontana; Stuart C. Gordon; Theo Heller; Scott D. Holmberg; Ravi Jhaveri; Maureen M. Jonas; Jennifer J. Kiser; Benjamin P. Linas; Vincent Lo Re; Timothy R. Morgan; Ronald G. Nahass; Marion G. Peters; K. Rajender Reddy; Andrew Reynolds; John D. Scott; Gloria Searson; Tracy Swan; Norah A. Terrault; Stacey B. Trooskin; John B. Wong; Kimberly A. Workowski

doi:10.1093/cid/ciy585

Hepatitis C guidance 2018 update: Aasld-idsa recommendations for testing, managing, and treating Hepatitis C Virus infection

Raymond T. Chung, Marc G. Ghany, Arthur Y. Kim, Kristen M. Marks, Susanna Naggie, Hugo E. Vargas, Andrew I. Aronsohn, Debika Bhattacharya, Tina Broder, Oluwaseun O. Falade-Nwulia, Robert J. Fontana, Stuart C. Gordon, Theo Heller, Scott D. Holmberg, Ravi Jhaveri, Maureen M. Jonas, Jennifer J. Kiser, Benjamin P. Linas, Vincent Lo Re, Timothy R. MorganRonald G. Nahass, Marion G. Peters, K. Rajender Reddy, Andrew Reynolds, John D. Scott, Gloria Searson, Tracy Swan, Norah A. Terrault, Stacey B. Trooskin, John B. Wong, Kimberly A. Workowski

Hepatology

Research output: Contribution to journal › Article › peer-review

244 Scopus citations

Abstract

Recognizing the importance of timely guidance regarding the rapidly evolving field of hepatitis C management, the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) developed a web-based process for the expeditious formulation and dissemination of evidence-based recommendations. Launched in 2014, the hepatitis C virus (HCV) guidance website undergoes periodic updates as necessitated by availability of new therapeutic agents and/or research data. A major update was released electronically in September 2017, prompted primarily by approval of new direct-acting antiviral agents and expansion of the guidance's scope. This update summarizes the latest release of the HCV guidance and focuses on new or amended recommendations since the previous September 2015 print publication. The recommendations herein were developed by volunteer hepatology and infectious disease experts representing AASLD and IDSA and have been peer reviewed and approved by each society's governing board.

Original language	English (US)
Pages (from-to)	1477-1492
Number of pages	16
Journal	Clinical Infectious Diseases
Volume	67
Issue number	10
DOIs	https://doi.org/10.1093/cid/ciy585
State	Published - Oct 30 2018

Keywords

HCV guidance
chronic HCV treatment
direct-acting antiviral treatment
hepatitis C

ASJC Scopus subject areas

Microbiology (medical)
Infectious Diseases

Access to Document

10.1093/cid/ciy585

Cite this

Chung, R. T., Ghany, M. G., Kim, A. Y., Marks, K. M., Naggie, S., Vargas, H. E., Aronsohn, A. I., Bhattacharya, D., Broder, T., Falade-Nwulia, O. O., Fontana, R. J., Gordon, S. C., Heller, T., Holmberg, S. D., Jhaveri, R., Jonas, M. M., Kiser, J. J., Linas, B. P., Lo Re, V., ... Workowski, K. A. (2018). Hepatitis C guidance 2018 update: Aasld-idsa recommendations for testing, managing, and treating Hepatitis C Virus infection. Clinical Infectious Diseases, 67(10), 1477-1492. https://doi.org/10.1093/cid/ciy585

Chung, RT, Ghany, MG, Kim, AY, Marks, KM, Naggie, S, Vargas, HE, Aronsohn, AI, Bhattacharya, D, Broder, T, Falade-Nwulia, OO, Fontana, RJ, Gordon, SC, Heller, T, Holmberg, SD, Jhaveri, R, Jonas, MM, Kiser, JJ, Linas, BP, Lo Re, V, Morgan, TR, Nahass, RG, Peters, MG, Reddy, KR, Reynolds, A, Scott, JD, Searson, G, Swan, T, Terrault, NA, Trooskin, SB, Wong, JB & Workowski, KA 2018, 'Hepatitis C guidance 2018 update: Aasld-idsa recommendations for testing, managing, and treating Hepatitis C Virus infection', Clinical Infectious Diseases, vol. 67, no. 10, pp. 1477-1492. https://doi.org/10.1093/cid/ciy585

@article{50d73a3302544745845a99427a393eaf,

title = "Hepatitis C guidance 2018 update: Aasld-idsa recommendations for testing, managing, and treating Hepatitis C Virus infection",

abstract = "Recognizing the importance of timely guidance regarding the rapidly evolving field of hepatitis C management, the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) developed a web-based process for the expeditious formulation and dissemination of evidence-based recommendations. Launched in 2014, the hepatitis C virus (HCV) guidance website undergoes periodic updates as necessitated by availability of new therapeutic agents and/or research data. A major update was released electronically in September 2017, prompted primarily by approval of new direct-acting antiviral agents and expansion of the guidance's scope. This update summarizes the latest release of the HCV guidance and focuses on new or amended recommendations since the previous September 2015 print publication. The recommendations herein were developed by volunteer hepatology and infectious disease experts representing AASLD and IDSA and have been peer reviewed and approved by each society's governing board.",

keywords = "HCV guidance, chronic HCV treatment, direct-acting antiviral treatment, hepatitis C",

author = "Chung, {Raymond T.} and Ghany, {Marc G.} and Kim, {Arthur Y.} and Marks, {Kristen M.} and Susanna Naggie and Vargas, {Hugo E.} and Aronsohn, {Andrew I.} and Debika Bhattacharya and Tina Broder and Falade-Nwulia, {Oluwaseun O.} and Fontana, {Robert J.} and Gordon, {Stuart C.} and Theo Heller and Holmberg, {Scott D.} and Ravi Jhaveri and Jonas, {Maureen M.} and Kiser, {Jennifer J.} and Linas, {Benjamin P.} and {Lo Re}, Vincent and Morgan, {Timothy R.} and Nahass, {Ronald G.} and Peters, {Marion G.} and Reddy, {K. Rajender} and Andrew Reynolds and Scott, {John D.} and Gloria Searson and Tracy Swan and Terrault, {Norah A.} and Trooskin, {Stacey B.} and Wong, {John B.} and Workowski, {Kimberly A.}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America.",

year = "2018",

month = oct,

day = "30",

doi = "10.1093/cid/ciy585",

language = "English (US)",

volume = "67",

pages = "1477--1492",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "10",

}

TY - JOUR

T1 - Hepatitis C guidance 2018 update

T2 - Aasld-idsa recommendations for testing, managing, and treating Hepatitis C Virus infection

AU - Chung, Raymond T.

AU - Ghany, Marc G.

AU - Kim, Arthur Y.

AU - Marks, Kristen M.

AU - Naggie, Susanna

AU - Vargas, Hugo E.

AU - Aronsohn, Andrew I.

AU - Bhattacharya, Debika

AU - Broder, Tina

AU - Falade-Nwulia, Oluwaseun O.

AU - Fontana, Robert J.

AU - Gordon, Stuart C.

AU - Heller, Theo

AU - Holmberg, Scott D.

AU - Jhaveri, Ravi

AU - Jonas, Maureen M.

AU - Kiser, Jennifer J.

AU - Linas, Benjamin P.

AU - Lo Re, Vincent

AU - Morgan, Timothy R.

AU - Nahass, Ronald G.

AU - Peters, Marion G.

AU - Reddy, K. Rajender

AU - Reynolds, Andrew

AU - Scott, John D.

AU - Searson, Gloria

AU - Swan, Tracy

AU - Terrault, Norah A.

AU - Trooskin, Stacey B.

AU - Wong, John B.

AU - Workowski, Kimberly A.

PY - 2018/10/30

Y1 - 2018/10/30

N2 - Recognizing the importance of timely guidance regarding the rapidly evolving field of hepatitis C management, the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) developed a web-based process for the expeditious formulation and dissemination of evidence-based recommendations. Launched in 2014, the hepatitis C virus (HCV) guidance website undergoes periodic updates as necessitated by availability of new therapeutic agents and/or research data. A major update was released electronically in September 2017, prompted primarily by approval of new direct-acting antiviral agents and expansion of the guidance's scope. This update summarizes the latest release of the HCV guidance and focuses on new or amended recommendations since the previous September 2015 print publication. The recommendations herein were developed by volunteer hepatology and infectious disease experts representing AASLD and IDSA and have been peer reviewed and approved by each society's governing board.

AB - Recognizing the importance of timely guidance regarding the rapidly evolving field of hepatitis C management, the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) developed a web-based process for the expeditious formulation and dissemination of evidence-based recommendations. Launched in 2014, the hepatitis C virus (HCV) guidance website undergoes periodic updates as necessitated by availability of new therapeutic agents and/or research data. A major update was released electronically in September 2017, prompted primarily by approval of new direct-acting antiviral agents and expansion of the guidance's scope. This update summarizes the latest release of the HCV guidance and focuses on new or amended recommendations since the previous September 2015 print publication. The recommendations herein were developed by volunteer hepatology and infectious disease experts representing AASLD and IDSA and have been peer reviewed and approved by each society's governing board.

KW - HCV guidance

KW - chronic HCV treatment

KW - direct-acting antiviral treatment

KW - hepatitis C

UR - http://www.scopus.com/inward/record.url?scp=85055612827&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055612827&partnerID=8YFLogxK

U2 - 10.1093/cid/ciy585

DO - 10.1093/cid/ciy585

M3 - Article

C2 - 30215672

AN - SCOPUS:85055612827

SN - 1058-4838

VL - 67

SP - 1477

EP - 1492

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 10

ER -

Hepatitis C guidance 2018 update: Aasld-idsa recommendations for testing, managing, and treating Hepatitis C Virus infection

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this